GENE ONLINE|News &
Opinion
Blog

MSD
Pearl Bio Enters $1 Billion Partnership Agreement with MSD for Biologic Therapies
2024-03-13
GeneOnline’s Weekly News Highlights: Oct 16-Oct 20
2023-10-24
Merck Joins Forces with Daiichi Sankyo in $5.5 Billion Deal to Develop Cancer Drugs
2023-10-22
World Premiere of Documentary-style Film on the Battle Against Antibiotic Resistance
2023-09-06
Merck Buys Prometheus For $10.8 Billion, Lands Promising Autoimmune Asset
2023-04-17
Moderna Gets $250 Million from MSD in Personal Cancer Vaccine Licensing Option
2022-10-12
FDA Blesses Merck’s Pneumococcal Vaccine for Pediatric Use
2022-06-23
EU Expands Merck’s Keytruda Use on Breast Cancer
2022-05-25
As India Suffers Crisis, Merck Signs License Pact with 5 Indian Firms to Manufacture COVID-19 Drugs
2021-04-29
Keytruda Receives Two New Approvals in Japan
2020-08-30
Weekly Cover: Takeda Initiates Development of Potential COVID-19 Therapy TAK-888
2020-03-13
HIV
Weekly in Asia 2019|AUG-1
2019-08-17
Lynparza Meets Primary Endpoint in Phase III PROfound Trial
2019-08-16
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
EVENT
Scroll to Top